Spiration, Inc. has made an announcement that its IBV® Valve System has been launched by Olympus in the European markets. The minimally invasive device is used for the treatment of various chronic lung problems. The system has already received the CE Mark for use in the treatment of serious diseases of the lung such as emphysema. Initially, the device will be presented to select physicians of Europe. The system may prove to be a boon for  patients who can not or do not undergo surgical operation. Spiration® will continue with manufacturing while Olympus does the distribution.

Olympus has come up with  its new Enzymatic Creatinine assay, that can be used across the range of Olympus diagnostic analyzers. Developed to determine the quantity of creatinine in human urine, serum and plasma, the novel assay makes use of an enzymatic method to attain greater precision, interfering lesser and lesser with antibiotics and bilirubin. It compliments the Jaffe technique, currently in use, measuring creatinine more exactly for specific cases in which the potential interference exists from diabetes, liver failure, renal failure and jaundice.